Short Interest in Vivos Inc. (OTCMKTS:RDGL) Decreases By 19.9%

Vivos Inc. (OTCMKTS:RDGL) was the recipient of a large decline in short interest in March. As of March 15th, there was short interest totalling 75,000 shares, a decline of 19.9% from the February 28th total of 93,600 shares. Based on an average daily volume of 822,100 shares, the short-interest ratio is currently 0.1 days. Currently, 0.0% of the shares of the stock are short sold.

Vivos Trading Down 1.7 %

RDGL stock opened at $0.12 on Monday. The company’s 50 day moving average is $0.13 and its 200 day moving average is $0.13. The stock has a market cap of $55.27 million, a price-to-earnings ratio of -12.19 and a beta of 0.89. Vivos has a 1-year low of $0.06 and a 1-year high of $0.26.

About Vivos

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.